Roll Call, March 2, 2023: Roll Call explains that FDA proposes broadening access to some common medications that currently require a doctor’s prescription. FDA suggests replacing prescriptions with a short quiz for over-the-counter access. We ask if patients will be careful enough to safely use these products.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Lawmakers, advocates press for diversity in clinical trials
National Journal, February 15, 2023: NCHR joins lawmakers and other advocates in urging FDA and NIH to improve diversity in race/ethnicity, age, and sex in clinical trials as a way to improve medical care for everyone. So far, enforcement is lacking.
Read More »American women still can’t get birth control pills without a prescription. This company has been trying for nine years to change that
FORTUNE, February 10, 2023: A company wants their birth control pill to be available over the counter. Is it safe enough to use without a prescription? It is safer than most hormonal contraceptives, but would this set a dangerous precedent for less safe contraceptives?
Read More »Many pediatric drug study results were never posted to a U.S. government database
STAT News, January 24, 2023: Results of 43 clinical trials involving thousands of children were never reported to clinicaltrials.gov or published in a medical journal or otherwise made publicly available, as required by law. We explain how this harms children and families.
Read More »Reassuring Safety Inquiry But Botched Comms Leads To Mixed Headlines For Pfizer Bivalent Vax
Pink Sheet, January 16, 2023: FDA and CDC failed to be transparent regarding their analysis of whether the Pfizer bivalent COVID vaccine increase strokes in older patients. There seems to be disagreement about how to explain the findings and the bottom line is that the agencies “don’t want to be asked questions” by experts in public.
Read More »